The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI US$ 29.96 Min. order: 1 piece ★★★★★ 4.8 (258 reviews) Sold : Login>>
Cellular Senescence as a Targetable Risk Factor for Cardiovascular Diseases: Therapeutic Implications: JACC Family Series US$ 27.93 Min. order: 1 piece ★★★★★ 5.0 (250 reviews) Sold : Login>>
TRANSLATING THE BIOLOGY OF AGING INTO NEW THERAPEUTICS FOR ALZHEIMER'S DISEASE: SENOLYTICS • The Journal of Prevention of Alzheimer's Disease US$ 25.35 Min. order: 1 piece ★★★★★ 4.9 (299 reviews) Sold : Login>>
Senolytics: charting a new course or enhancing existing anti-tumor therapies? | Cellular Oncology US$ 21.01 Min. order: 1 piece ★★★★★ 4.1 (28 reviews) Sold : Login>>
Senolytic Drugs Market Research Report 2034 US$ 21.23 Min. order: 1 piece ★★★★★ 4.0 (51 reviews) Sold : Login>>